Rishi Agarwal

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (18)

• SYSTEMIC EMBOLIZATION OF METAPLASTIC BREAST CANCER THROUGH PULMONARY VEIN
  Journal of the American College of Cardiology 2019 DOI: 10.1016/S0735-1097(19)33443-6
  +Save
• Lymphopenia as a predictor of survival in chemoradiation-treated stage III non-small-cell lung cancer (NSCLC): a multi-center retrospective analysis
  Journal of Radiation Oncology 2019 DOI: 10.1007/S13566-019-00384-0
  +Save
• Phase I study of nab-paclitaxel, gemcitabine, and bevacizumab in patients with advanced cancers
  British Journal of Cancer 2018 DOI: 10.1038/S41416-018-0068-Z
  +Save
• Personalized Medicine in Hereditary Cancer Syndromes
  Cancer Genetics and Genomics for Personalized Medicine 2017 DOI: 10.1201/9781315364766-10
  +Save
• Advanced biliary tract cancer: clinical outcomes with ABC-02 regimen and analysis of prognostic factors in a tertiary care center in the United States
  Journal of Gastrointestinal Oncology 2016 DOI: 10.21037/JGO.2016.09.10
  +Save
• Response to Targeted Therapy in BRAF Mutant Anaplastic Thyroid Cancer
  JNCCN–Journal of the National Comprehensive Cancer Network 2016 DOI: 10.6004/JNCCN.2016.0130
  +Save
• Targeted Therapy for Genetic Cancer Syndromes: Fanconi Anemia, Medullary Thyroid Cancer, Tuberous Sclerosis, and RASopathies
  Discovery Medicine 2015
  +Save
• Targeted Therapy for Genetic Cancer Syndromes: Von Hippel-Lindau Disease, Cowden Syndrome, and Proteus Syndrome
  Discovery Medicine 2015
  +Save
• Targeted Therapy for Hereditary Cancer Syndromes: Hereditary Breast and Ovarian Cancer Syndrome, Lynch Syndrome, Familial Adenomatous Polyposis, and Li-Fraumeni Syndrome
  Discovery Medicine 2014
  +Save
• Targeted Therapy for Hereditary Cancer Syndromes: Neurofibromatosis Type 1, Neurofibromatosis Type 2, and Gorlin Syndrome
  Discovery Medicine 2014
  +Save